{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:45:31Z","timestamp":1781333131738,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alternative Funding Plan Innovation Fund, Women's College Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People with moderate to severe depression in pregnancy must weigh potential risks of untreated or incompletely treated depression against the small, but uncertain risks of fetal antidepressant drug exposure. Clinical support alone appears insufficient for helping individuals with this complex decision. A patient decision aid (PDA) has the potential to be a useful tool for this population. The objective of our work was to use internationally recognized guidelines from the International Patient Decision Aids Standards Collaboration to develop an evidence-based PDA for antidepressant use in pregnancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A three-phased development process was used whereby, informed by patient and physician perspectives and evidence synthesis, a steering committee commissioned a web-based PDA for those deciding whether or not to start or continue antidepressant treatment for depression in pregnancy (Phase 1). A prototype was developed (Phase 2) and iteratively revised based on feedback during field testing based on a user-centred process (Phase 3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We developed a web-based PDA for people deciding whether to start or continue antidepressant use for depression in pregnancy. It has five interactive sections: (1) information on depression and treatment; (2) reasons to start\/continue an antidepressant and to start\/stop antidepressant medication; (3) user assessment of values regarding each issue; (4) opportunity to reflect on factors that contribute to decision making; and (5) a printable PDF that summarizes the user\u2019s journey through the PDA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This tool, which exclusively focuses on depression treatment with Selective\u00a0Serotonin Reuptake Inhibitors and Serotonin\u2013Norepinephrine Reuptake Inhibitors, can be used by individuals making decisions about antidepressant use to treat depression during pregnancy. Limitations of the PDA are that it is not for other conditions, nor other medications that can be used for depression, and in its pilot form cannot be used by women who do not speak English or who have a visual impairment. Pending further study, it has the potential to enhance quality of care and patient experience.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-022-01870-1","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T10:04:30Z","timestamp":1652436270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The development of a patient decision aid to reduce decisional conflict about antidepressant use in pregnancy"],"prefix":"10.1186","volume":"22","author":[{"given":"Neesha","family":"Hussain-Shamsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Somerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Oberlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Schram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy-Lee","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone N.","family":"Vigod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"issue":"4","key":"1870_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/01.AOG.0000116689.75396.5f","volume":"103","author":"HA Bennett","year":"2004","unstructured":"Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obs Gynecol. 2004;103(4):698\u2013709.","journal-title":"Obs Gynecol"},{"issue":"1","key":"1870_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/oxfordjournals.epirev.a036172","volume":"17","author":"ST Orr","year":"1995","unstructured":"Orr ST, Miller CA. Maternal depressive symptoms and the risk of poor pregnancy outcome: review of the literature and preliminary findings. Epidemiol Rev. 1995;17(1):165\u201371.","journal-title":"Epidemiol Rev"},{"issue":"5","key":"1870_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","volume":"166","author":"KL Wisner","year":"2009","unstructured":"Wisner KL, Sit DKY, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, et al. Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166(5):557\u201366.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1870_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jamapsychiatry.2016.0934","volume":"73","author":"A Jarde","year":"2016","unstructured":"Jarde A, Morais M, Kingston D, Giallo R, MacQueen GM, Giglia L, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: A systematic review and meta-analysis. JAMA Psychiat. 2016;73(8):826\u201337.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"1870_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bpobgyn.2013.08.009","volume":"28","author":"S Meltzer-Brody","year":"2014","unstructured":"Meltzer-Brody S, Stuebe A. The long-term psychiatric and medical prognosis of perinatal mental illness. Best Pr Res Clin Obs Gynaecol. 2014;28(1):49\u201360.","journal-title":"Best Pr Res Clin Obs Gynaecol"},{"key":"1870_CR6","doi-asserted-by":"publisher","first-page":"i1547","DOI":"10.1136\/bmj.i1547","volume":"352","author":"SN Vigod","year":"2016","unstructured":"Vigod SN, Wilson CA, Howard LM. Depression in pregnancy. BMJ. 2016;352:i1547.","journal-title":"BMJ"},{"issue":"1","key":"1870_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0883-9417(98)80004-6","volume":"12","author":"CT Beck","year":"1998","unstructured":"Beck CT. The effects of postpartum depression on child development: A meta-analysis. Arch Psychiatr Nurs. 1998;12(1):12\u201320.","journal-title":"Arch Psychiatr Nurs"},{"issue":"3","key":"1870_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/archpsyc.60.3.253","volume":"60","author":"C Hammen","year":"2003","unstructured":"Hammen C, Brennan PA. Severity, chronicity, and timing of maternal depression and risk for adolescent offspring diagnoses in a community sample. Arch Gen Psychiatry. 2003;60(3):253\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"1870_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/1469-7610.00661","volume":"41","author":"C Martins","year":"2000","unstructured":"Martins C, Gaffan EA. Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry Allied Discip. 2000;41(6):737\u201346.","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"issue":"1","key":"1870_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09540269609037816","volume":"8","author":"MW O\u2019Hara","year":"1996","unstructured":"O\u2019Hara MW, Swain AM. Rates and risk of postpartum depression\u2014a meta-analysis. Int Rev Psychiatry. 1996;8(1):37\u201354.","journal-title":"Int Rev Psychiatry"},{"issue":"Suppl 2","key":"1870_CR11","first-page":"53","volume":"59","author":"KM Weinberg","year":"1998","unstructured":"Weinberg KM, Tronick EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry. 1998;59(Suppl 2):53\u201361.","journal-title":"J Clin Psychiatry"},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuroscience.2015.09.001","volume":"342","author":"S Gentile","year":"2017","unstructured":"Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154\u201366.","journal-title":"Neuroscience"},{"issue":"3","key":"1870_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/070674371205700305","volume":"57","author":"A Bowen","year":"2012","unstructured":"Bowen A, Bowen R, Butt P, Rahman K, Muhajarine N. Patterns of depression and treatment in pregnant and postpartum women. Can J Psychiatry. 2012;57(3):161\u20137.","journal-title":"Can J Psychiatry"},{"issue":"9","key":"1870_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0706743716659276","volume":"61","author":"GM MacQueen","year":"2016","unstructured":"MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Van Lieshout RJ, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly. Can J Psychiatry. 2016;61(9):588\u2013603.","journal-title":"Can J Psychiatry"},{"issue":"7","key":"1870_CR15","first-page":"467","volume":"49","author":"C-L Dennis","year":"2004","unstructured":"Dennis C-L, Stewart DE. Treatment of postpartum depression, part 1: a critical review of biological interventions. J Clin Psychiatry. 2004;49(7):467\u201375.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"1870_CR16","first-page":"526","volume":"49","author":"CLE Dennis","year":"2004","unstructured":"Dennis CLE. Treatment of postpartum depression, part 2: a critical review of nonbiological interventions. J Clin Psychiatry. 2004;49(8):526\u201338.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"1870_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3122\/jabfm.16.5.372","volume":"16","author":"D Gjerdingen","year":"2003","unstructured":"Gjerdingen D. The effectiveness of various postpartum depression treatments and the impact of antidepressant drugs on nursing infants. J Am Board Fam Pract. 2003;16(5):372\u201382.","journal-title":"J Am Board Fam Pract"},{"issue":"10","key":"1870_CR18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1517\/14656566.3.10.1421","volume":"3","author":"V Sharma","year":"2002","unstructured":"Sharma V. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother. 2002;3(10):1421\u201331.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"1870_CR19","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry. 2006;163(11):1905\u201317.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1870_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.295.5.499","volume":"295","author":"LS Cohen","year":"2006","unstructured":"Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. J Am Med Assoc. 2006;295(5):499\u2013507.","journal-title":"J Am Med Assoc"},{"key":"1870_CR21","doi-asserted-by":"publisher","first-page":"b3569","DOI":"10.1136\/bmj.b3569","volume":"339","author":"LH Pedersen","year":"2009","unstructured":"Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: Population based cohort study. BMJ. 2009;339:b3569.","journal-title":"BMJ"},{"issue":"11","key":"1870_CR22","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","volume":"156","author":"AM Costei","year":"2002","unstructured":"Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002;156(11):1129\u201332.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"1870_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s002280050664","volume":"55","author":"A Ericson","year":"1999","unstructured":"Ericson A, K\u00e4ll\u00e9n B, Wiholm BE. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol. 1999;55(7):503\u20138.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1870_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.279.8.609","volume":"279","author":"NA Kulin","year":"1998","unstructured":"Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors; A prospective controlled multicenter study. J Am Med Assoc. 1998;279(8):609\u201310.","journal-title":"J Am Med Assoc"},{"issue":"7","key":"1870_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","volume":"60","author":"K Laine","year":"2003","unstructured":"Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60(7):720\u20136.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1870_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","volume":"160","author":"R Levinson-Castiel","year":"2006","unstructured":"Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"1870_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1203\/00006450-200204000-00008","volume":"51","author":"TF Oberlander","year":"2002","unstructured":"Oberlander TF, Grunau RE, Fitzgerald C, Ellwood AL, Misri S, Rurak D, et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res. 2002;51(4):443\u201353.","journal-title":"Pediatr Res"},{"issue":"2","key":"1870_CR28","doi-asserted-by":"publisher","first-page":"F134","DOI":"10.1136\/fn.84.2.F134","volume":"84","author":"JA Stiskal","year":"2001","unstructured":"Stiskal JA, Kulin N, Koren G, Ho T, Ito S. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F134-135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","volume":"335","author":"CD Chambers","year":"1996","unstructured":"Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth Outcomes in Pregnant Women Taking Fluoxetine. N Engl J Med. 1996;335:1010\u20135.","journal-title":"N Engl J Med"},{"key":"1870_CR30","doi-asserted-by":"publisher","first-page":"d8012","DOI":"10.1136\/bmj.d8012","volume":"344","author":"H Kieler","year":"2012","unstructured":"Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. BMJ. 2012;344:d8012.","journal-title":"BMJ"},{"issue":"4","key":"1870_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","volume":"194","author":"SW Wen","year":"2006","unstructured":"Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194(4):961\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"1870_CR32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","volume":"169","author":"I Nulman","year":"2012","unstructured":"Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012;169(11):1165\u201374.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1870_CR33","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/npp.2011.67","volume":"36","author":"EJH Mulder","year":"2011","unstructured":"Mulder EJH, Ververs FFT, De Heus R, Visser GHA. Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology. 2011;36(10):1961\u201371.","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"1870_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/da.20844","volume":"28","author":"SR Patel","year":"2011","unstructured":"Patel SR, Wisner KL. Decision making for depression treatment during pregnancy and the postpartum period. Depress Anxiety. 2011;28(7):589\u201395.","journal-title":"Depress Anxiety"},{"issue":"2","key":"1870_CR35","doi-asserted-by":"publisher","first-page":"e026121","DOI":"10.1136\/bmjopen-2018-026121","volume":"9","author":"AR Gagliardi","year":"2019","unstructured":"Gagliardi AR, Dunn S, Foster A, Grace SL, Green CR, Khanlou N, et al. How is patient-centred care addressed in women\u2019s health? A theoretical rapid review. BMJ Open. 2019;9(2):e026121.","journal-title":"BMJ Open"},{"issue":"11","key":"1870_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/070674370404901103","volume":"49","author":"L Bonari","year":"2004","unstructured":"Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry. 2004;49(11):726\u201335.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"1870_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00737-014-0448-1","volume":"17","author":"GD Walton","year":"2014","unstructured":"Walton GD, Ross LE, Stewart DE, Grigoriadis S, Dennis CL, Vigod S. Decisional conflict among women considering antidepressant medication use in pregnancy. Arch Womens Ment Heal. 2014;17(6):493\u2013501.","journal-title":"Arch Womens Ment Heal"},{"key":"1870_CR38","first-page":"486","volume-title":"Nursing diagnosis and intervention","author":"A O\u2019Connor","year":"1997","unstructured":"O\u2019Connor A. Decisional conflict. In: McFarland G, McFarlane E, editors. Nursing diagnosis and intervention. St. Louis: CV Mosby Co; 1997. p. 486\u201396."},{"issue":"5","key":"1870_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0272989X07307272","volume":"27","author":"M Holmes-Rovner","year":"2007","unstructured":"Holmes-Rovner M, Nelson WL, Pignone M, Elwyn G, Rovner DR, O\u2019Connor AM, et al. Are patient decision aids the best way to improve clinical decision making? Report of the IPDAS symposium. Med Decis Mak. 2007;27(5):599\u2013608.","journal-title":"Med Decis Mak"},{"key":"1870_CR40","unstructured":"Volk RJ, Llewellyn-Thomas H. The 2012 IPDAS background document: an introduction. In: Volk RJ, Llewellyn-Thomas H, editors. 2012 Update of the International Patient Decision Aids Standards (IPDAS) Collaboration\u2019s Background Document. 2012."},{"key":"1870_CR41","doi-asserted-by":"crossref","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4(4).CD001431","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"1870_CR42","unstructured":"Coulter A, Kryworuchko J, Mullen PD, Ng C-K, Stilwell D, van der Weijden T. Chapter A: Using a systematic development process. In: Volk RJ, Llewellyn-Thomas H, editors. Update of the International Patient Decision Aids Standards (IPDAS) Collaboration\u2019s Background Document. 2012."},{"key":"1870_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2019.01.051","volume":"251","author":"SN Vigod","year":"2019","unstructured":"Vigod SN, Hussain-Shamsy N, Stewart DE, Grigoriadis S, Metcalfe K, Oberlander TF, et al. A patient decision aid for antidepressant use in pregnancy: Pilot randomized controlled trial. J Affect Disord. 2019;251:91\u20139.","journal-title":"J Affect Disord"},{"issue":"2","key":"1870_CR44","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1472-6947-13-S2-S4","volume":"13","author":"D Feldman-Stewart","year":"2013","unstructured":"Feldman-Stewart D, O\u2019Brien MA, Clayman ML, Davison BJ, Jimbo M, Labrecque M, et al. Providing information about options in patient decision aids. BMC Med Inform Decis Mak. 2013;13(2):S4.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"1870_CR45","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1472-6947-13-S2-S6","volume":"13","author":"P Abhyankar","year":"2013","unstructured":"Abhyankar P, Volk RJ, Blumenthal-Barby J, Bravo P, Buchholz A, Ozanne E, et al. Balancing the presentation of information and options in patient decision aids: an updated review. BMC Med Inform Decis Mak. 2013;13(2):S6.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"1870_CR46","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1472-6947-13-S2-S7","volume":"13","author":"LJ Trevena","year":"2013","unstructured":"Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PKJ, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13(2):S7.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"1870_CR47","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1472-6947-13-S2-S10","volume":"13","author":"KJ McCaffery","year":"2013","unstructured":"McCaffery KJ, Holmes-Rovner M, Smith SK, Rovner D, Nutbeam D, Clayman ML, et al. Addressing health literacy in patient decision aids. BMC Med Inform Decis Mak. 2013;13(2):S10.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7417","key":"1870_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/bmj.327.7417.745","volume":"327","author":"J Paling","year":"2003","unstructured":"Paling J. Strategies to help patients understand risks. BMJ. 2003;327(7417):745\u20138.","journal-title":"BMJ"},{"key":"1870_CR49","doi-asserted-by":"crossref","unstructured":"Ahmed H, Naik G, Willoughby H, Edwards AGK. Communicating risk. BMJ. 2012;344.e3996","DOI":"10.1136\/bmj.e3996"},{"issue":"1","key":"1870_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989X9501500105","volume":"15","author":"A O\u2019Connor","year":"1995","unstructured":"O\u2019Connor A. Validation of a decisional conflict scale. Med Decis Mak. 1995;15(1):25\u201330.","journal-title":"Med Decis Mak"},{"key":"1870_CR51","unstructured":"O\u2019Connor A. User manual\u2014decisional conflict scale [Internet]. Ottawa Hospital Research Institute, Ottawa. 2010 [cited 2021 Oct 19]. https:\/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Decisional_Conflict.pdf"},{"issue":"2","key":"1870_CR52","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/1472-6947-13-S2-S8","volume":"13","author":"A Fagerlin","year":"2013","unstructured":"Fagerlin A, Pignone M, Abhyankar P, Col N, Feldman-Stewart D, Gavaruzzi T, et al. Clarifying values: an updated review. BMC Med Inform Decis Mak. 2013;13(2):S8.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1870_CR53","doi-asserted-by":"crossref","unstructured":"Khalifeh H, Molyneaux E, Brauer R, Vigod S, Howard LM. Patient decision aids for antidepressant use in pregnancy: a pilot randomised controlled trial in the UK. BJGP Open. 2019;3(4).bjgpopen19X101666.","DOI":"10.3399\/bjgpopen19X101666"},{"issue":"3","key":"1870_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/NCN.0b013e31819f7c7c","volume":"27","author":"ADV Dabbs","year":"2009","unstructured":"Dabbs ADV, Myers BA, Mc Curry KR, Dunbar-Jacob J, Hawkins RP, Begey A, et al. User-centered design and interactive health technologies for patients. CIN Comput Inform Nurs. 2009;27(3):175\u201383.","journal-title":"CIN Comput Inform Nurs"},{"issue":"2","key":"1870_CR55","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1472-6947-13-S2-S2","volume":"13","author":"A Coulter","year":"2013","unstructured":"Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(2):S2.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"1870_CR56","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jamia\/ocaa067","volume":"27","author":"J Wosik","year":"2020","unstructured":"Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27(6):957\u201362.","journal-title":"J Am Med Inform Assoc"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01870-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-01870-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01870-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T12:07:47Z","timestamp":1652443667000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-01870-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-01870-1","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and ethics approvals to conduct the study were obtained from the Women\u2019s College Hospital Research Ethics Board (REB# 2014-0050B). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SNV and DES report royalties from UpToDate for authorship of materials related to antidepressants in pregnancy. SG reports royalties from UpToDate and Psychotherapy Essentials to Go for authorship of materials related to treatment of depression in pregnancy. DES serves on the Medical Advisory Committee of Lilly\u2019s Cymbalta Pregnancy Registry. The other authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}